SCHEMBL4898749

SCHEMBL4898749

Cc1nccc(OCc2ccccc2)c1OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.53
MAPT P10636 1/20 0.53
MAPK1 P28482 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
STAT3 P40763 1/20 0.50
HTT P42858 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
LTA4H P09960 1/20 0.47
MAPK14 Q16539 1/20 0.47
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.46
LIPE Q05469 1/20 0.45
MAOA P21397 1/20 0.44
ATP4A P20648 1/20 0.43
ATP4B P51164 1/20 0.43
BRD4 O60885 4/20 0.43
POLB P06746 1/20 0.43
ABCB1 P08183 1/20 0.43
HTR1A P08908 2/20 0.42
PTPN1 P18031 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4688192 0.90 L3MBTL1 (0.50) L3MBTL1MAPTMAPK1TDP1STAT3
SCHEMBL5583648 0.90 BCHE (0.50) L3MBTL1MAPTMAPK1TDP1STAT3
SCHEMBL4140684 0.90 ABCB1 (0.53) L3MBTL1MAPTMAPK1TDP1HTT
SCHEMBL16740415 0.84 MAOA (0.39) L3MBTL1MAPTMAPK1TDP1STAT3
SCHEMBL16356781 0.84 L3MBTL1 (0.65) L3MBTL1MAPTMAPK1TDP1STAT3
SCHEMBL6197763 0.84 PTPN1 (0.65) L3MBTL1MAPTMAPK1TDP1SMN1; SMN2
SCHEMBL4149747 0.81 LMNA (0.48) L3MBTL1MAPTMAPK1TDP1STAT3
SCHEMBL31517959 0.81 L3MBTL1 (0.51) L3MBTL1MAPTMAPK1TDP1STAT3
SCHEMBL9682836 0.81 LMNA (0.45) L3MBTL1MAPTMAPK1TDP1STAT3
SCHEMBL9176447 0.81 PTGER1 (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200520-A1 Iron Modulators BTG INTERNATIONAL LIMITED 2008-08-21 US disclosed
WO-2006103463-A1 IRON MODULATORS BTG INTERNATIONAL LIMITED (GB) 2006-10-05 WO disclosed
US-5112968-A Monobactam hydrazide derivatives E. R. SQUIBB & SONS, INC. (US) 1992-05-12 US disclosed
EP-0336369-A1 3-Acylamino-1-[[[(substituted sulfonyl)amino]carbonyl]amino]2-azetidinones E.R. Squibb & Sons, Inc. (US) 1989-10-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200520-A1 Iron Modulators SLC40A1, HAMP, FTH1 L3MBTL1 793/4885MAPT 109/4885MAPK1 3328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.